Urological Society for
American Veterans
2023 USAV Annual Meeting (during the AUA Annual Meeting)
Chicago - Sunday, April 30, 10:30am to 2:30pm
Hyatt Regency McCormick Place - Regency Ballroom CDE
2023 Program Highlights:
- Pathways to fund your research at VA
- Theranostics in Prostate Cancer
- Establishing Male Infertility Program in VA: tips and tricks
- Disposable ureteroscopes: Are they worth it?
- Lunch Included - must RSVP for ticket
USAV MEETING CHICAGO - DETAILED SCHEDULE (REV MAR 1, 2023)
Sunday, April 30, 2023, 10:00 AM - 2:30 PM
Hyatt Regency McCormick Place
Regency Ballroom CDE
| TIME | PRESENTATION | SPEAKER |
| 10:00 AM | Check-in / Exhibit set up / Network with Physicians | |
| 10:30 AM | Welcome / USAV Update | Robert L. Grubb III, MD, President, Medical University of South Carolina, Ralph H. Johnson VA Medical Center / Abhinav Sidana, MD, Scientific Program Chair, University of Cincinnati College of Medicine |
| 10:35 AM | Pathways to fund your research in the Veterans Health Administration. | Ted Skolarus, MD, MPH, FACS, University of Chicago, VA Ann Arbor Healthcare System |
| 10:55 AM | Establishing Male Infertility Program in VA: tips and tricks. | Sarah C. Krzastek, MD, Central Virginia VA Health Care System |
| 11:15 AM | Disposable ureteroscopes: Are they worth it? | Bodo E. Knudsen, MD, Ohio State Univ. Wexner Med. Ctr. |
| 11:35 AM | Sponsor highlights (1 slide each) | |
| 11:45 AM | Lunch Break /review Posters/ Visit Exhibits | |
| PAPER ID# | Viewing of Unmoderated Posters | Moderator: Sudhir Isharwal, MD |
| #06 | Postoperative PSA testing after radical prostatectomy: when should the initial PSA be obtained? | Emily Fisher, (3rd year Med. Student) |
| #07 | Examining the Utility of an Exosome-Based Urine Test in Prostate Cancer Screening in a Veteran Population. | Sarah C. Krzastek, MD |
| #08 | Physical Activity, Frailty, and Functional Outcomes in Men undergoing Androgen Deprivation Therapy. | Aubrey K. Jarman, BS, RD |
| #09 | Management of Patients that do not Achieve an Undetectable PSA After Prostatectomy. | Dennis Boynton, BS |
| #10 | Race, geography, and prostate cancer outcomes in patients treated in the VA Health Care System. | Ivy T. Liu BS |
| #11 | Using the Femoral Head Size to Determine Prostate Volume from Cross-sectional Imaging. | Samuel J. Han |
| #12 | The association between C-reactive protein levels and prostate cancer recurrence in nonmetastatic radical prostatectomy patients. | Ieva Juzumaite, BA |
| #13 | Negative PSA Velocity and Its Impact on Patients With Elevated PSA. | Alexander H. Fang, BS |
| #14 | Preferences for interventions to address unmet sexual health information and support needs among female partners of men with prostate cancer. | Natasha Gupta, MD |
| #15 | The histopathological basis of false positive PI-RADS 4/5 lesions. | Nilesh Patil, MD |
| #16 | Do Hispanic Puerto Rican men have worse outcomes after radical prostatectomy? Results from Shared Equal Access Regional Cancer Hospital (SEARCH). | Lourdes Guerrios-Rivera, MD |
| #18 | Extreme-Low-Dose (XLD) Intraoperative CT scan (ICT) (<0.5 mSv) Achieved During Percutaneous Stone Treatments using a Robotic Multiplanar Fluoroscopy Systems (RMPFS) | Brett M. Wiesen, MD |
| 12:55 PM | Industry Supported Talk during Lunch - TBD | |
| 1:15 PM | Podium Presentations - 4 min each / 5 slides | Moderator: Thomas A. Masterson, MD |
| PAPER ID# | TITLE | PRESENTER |
| #01 | Survival Comparison of Inflatable Penile Prosthesis Placement at a Veterans Affairs Medical Center Compared to A Tertiary Referral Center. | Parth Thakker, MD |
| #02 | Variances in pathologic findings at biopsy in equal access Veteran’s Administration Hospital following the 2018 USPSTF PSA screening recommendations. | Karl-Ray O. Jeune, BA |
| #03 | Prostate Biopsy Sepsis Prevention: External Validation of an Isopropyl Alcohol Needle Washing Protocol. |
Anthony Hiffa, MD, MPH |
| #04 | Representation Matters for Black Patients with Prostate Cancer: Qualitative Study of Digital Information. | Stacy Loeb, MD, MSc, PhD |
| #05 | Accurate Documentation Contributes to Guideline Concordant Surveillance of Non-Muscle Invasive Bladder Cancer: a Multi-site VA Study. | Vikram Lyall, MD |
| #17 | Changes in Serial Decipher Genomic Classifier Testing Among Patients with Prostate Cancer Managed with Active Surveillance. | Ghazal Khajir, MD |
| 1:50 PM | Active Surveillance 2.0: Impact of MRI and biomarkers on surveillance strategy. | Stacy Loeb, MD, MSc, PhD, NYU Lagone Health and Manhattan Veterans Affairs |
| 2:10 PM | NSO Update. | Jeremy Shelton, MD |
| 2:15 PM | Awards / Prize Drawings | Abhinav Sidana, MD / Robert Grubb, MD |
| 2:30 PM | End of Meeting |
We gratefully acknowledge these exhibiting companies for supporting our 2022 meeting!
PLATINUM SUPPORTERS: EXACT SCIENCES • PROCEPT BIOROBOTICS
GOLD SUPPORTERS: EXOSOME DIAGNOSTICS • GUERBET • KARL STORZ ENDOSCOPY
SILVER SUPPORTERS: DECIPHER UROLOGIC CANCERS • BK MEDICAL • PACIFIC EDGE DIAGNOSTICS • PHOTOCURE • LANTHEUS • TELEFLEX .....................................SONABLATE CORP • WELLSPECT HEALTHCARE